Artiva Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(40.6%),Peter Kolchinsky(40.6%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-venBio Global Strategic Fund III, L.P.(7.8%),venBio Global Strategic GP III, L.P.(7.8%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Andrew J. Schwab(10.1%),Kush Parmar(10.1%), etc.
Artiva Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Venrock Healthcare Capital Partners III, L.P.(6.9%),VHCP Co-Investment Holdings III, LLC(6.9%), etc.
Artiva Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(42.3%),Peter Kolchinsky(42.3%), etc.
Artiva Biotherapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-GC Corp.(19.6%),Yong-Jun Huh(19.6%), etc.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner 5AM Partners VI, LLC
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner GC Corp.
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Huh Yong-Jun
Artiva Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Aslan Fred
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner venBio Global Strategic Fund III, L.P.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner 5AM Partners VI, LLC
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director Miralles Gines Diego
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-10% Owner Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director Stoppel Laura
Artiva Biotherapeutics, Inc. | 3: Initial statement of beneficial ownership of securities-Director HOUGEN ELIZABETH L
No Data